Close Menu
    Quds SunQuds Sun
    • Automotive
    • Business
    • Entertainment
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Quds SunQuds Sun
    Home » Innovative experimental malaria drug based on antibodies discovered
    Featured News

    Innovative experimental malaria drug based on antibodies discovered

    November 1, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    A new study in Africa has found that a one-time dose of an experimental drug protects adults against malaria for at least six months. In 2020, malaria killed more than 620,000 people and sickened 241 million, mostly children under 5. There is a malaria vaccine being rolled out by the World Health Organization for children, but it is only 30% effective and requires four doses.

    Innovative experimental malaria drug based on antibodies discoveredIn this new study, people received a large dose of lab-made malaria-fighting antibodies instead of relying on the immune system to make enough of those same infection-blockers after vaccination, reported the Associated Press (AP). “There are not enough people protected by the vaccine available,” said Kassoum Kayentao, a researcher from the University of Sciences, Techniques and Technologies in Bamako, Mali.

    In those villages, people are bitten by infected mosquitoes on average twice a day during malaria season, according to other research. Experimental antibody, developed by researchers at the US National Institutes of Health, was delivered by IV. In the meantime, an easy-to-administer shot version from the same scientists is in early testing in infants, children, and adults.

    Research presented at a medical meeting in Seattle was published Monday in the New England Journal of Medicine. In order to work, the antibody breaks the life cycle of the parasite, which is spread through mosquito bites. It targets immature parasites before they mature and multiply in the liver. An antibody taken from a volunteer who received a malaria vaccine was used to develop it.

    It involved 330 adults in Mali who received either a dummy infusion or two different antibody doses. Every two weeks for 24 weeks, all were tested for malaria infection. Treatment was provided to anyone who became ill. A blood test detected infections in 20 people who received the higher dose, 39 people who received the lower dose, and 86 people who received the placebo. Compared to the placebo, the higher dose was 88% effective. There was a 75% effectiveness rate for the lower dose.

    During a malaria season, protection might last for several months. In the future, it could be used in conjunction with other malaria prevention methods, such as malaria pills, mosquito nets, and vaccinations. According to one estimate, lab-made antibodies could be given for as little as $5 per child per malaria season.

    Related Posts

    Tüyap highlights MENA sourcing opportunities at the carpet expo in Istanbul

    November 17, 2026

    Integrated Identity Unveils Proprietary Global Media Infrastructure

    October 22, 2026

    VisionHammer expands into the Gulf and US with AI software assurance

    October 20, 2026

    Bitmanager researchers presented scientific papers at Interspeech 2026

    October 12, 2026

    From 350+ Applications to One Champion: School of Cyber Defense Final Stage at GISEC GLOBAL 2026

    September 21, 2026

    JETOUR G700 TOPFIRE Set to Redefine Flagship Off-Road Performance in the UAE

    September 18, 2026
    Latest News

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    – The South African rand is caught between rising inflation and weak economic growth as the country faces a week of key decisions on prices and interest rates. Higher petrol prices pushed consumer inflation sharply higher in October, while soft

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

    November 18, 2026

    Tunisia tourism revenues top $2.38 billion by end-October

    November 17, 2026

    Strong bookings push Etihad Calgary flights to daily service

    November 17, 2026

    UAE President and Venezuela’s acting leader discuss closer ties

    November 17, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026
    © 2026 Quds Sun | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.